RxDoctor Payments Data

Gannon Nyquist, PA

Physician Assistant · Vallejo, CANPI 1134793169

Payments from drug & device makers

$384in general payments, 2019–2025

Across 15 payments — averaging $25.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$61
  • AstraZeneca$58
  • GSK$57
  • Boehringer Ingelheim$36
  • Mylan Specialty L.p.$30
  • Inspire Medical Systems, Inc.$24
  • plus $118 from 6 others

What the payments were for

  • Food & beverage$384100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$384 in reported general payments places this provider in the 55th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$52,493
Medicare patients
349
Services billed
499

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter539$399,112
Breztri AerosphereBudesonide/Glycopyr/Formoterol115$79,124
Spiriva RespimatTiotropium Bromide44$23,820
Combivent RespimatIpratropium/Albuterol Sulfate30$20,713
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr27$16,432
Fluticasone-SalmeterolFluticasone Propion/Salmeterol100$14,854
Stiolto RespimatTiotropium Br/Olodaterol Hcl18$12,797
Breo ElliptaFluticasone/Vilanterol29$11,352
Albuterol Sulfate HfaAlbuterol Sulfate259$9,776
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate29$9,413
SymbicortBudesonide/Formoterol Fumarate25$7,154
Advair HfaFluticasone Propion/Salmeterol14$5,295
Incruse ElliptaUmeclidinium Bromide15$5,089
Azelastine Hcl84$1,252
Montelukast Sodium170$1,192

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta$57$431,985610 claims
AstraZenecaBreztri Aerosphere, Symbicort$58$86,278140 claims
Boehringer IngelheimSpiriva Respimat, Combivent Respimat, Stiolto Respimat$36$57,33092 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Vallejo

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →